Steffen Walter is the founder of immatics biotechnologies. immatics biotechnologies has raised $230M in total funding. Based in Tuebingen, Germany.
Steffen Walter is the Chief Technology Officer at Immatics, a clinical-stage biopharmaceutical company. Immatics specializes in the discovery and development of T cell redirecting cancer immunotherapies. The company uses personalized approaches to modify patient's T cells for cancer treatment. Immatics collaborates with UTHealth for cGMP manufacturing infrastructure.
Full founder directory · Investor directory · Company funding database · Fundraising library